Sponsor pipeline

Arbor Biotechnologies clinical trial pipeline

Get alerts when Arbor Biotechnologies's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06839235 Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine) Primary Hyperoxaluria Type 1 (PH1) Recruiting 2026-02-12
Get alerts when Arbor Biotechnologies's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free